A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems
Frontiers in Public Health · 24.06.2026 · 14
DOI: 10.3389/fpubh.2026.1817705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 24.06.2026. Verfasst von Alexandra Costa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion and NCDs Prevention, National Health of Institute Doctor Ricardo Jorge, Lisbon, Portugal. Hauptthemen laut MEDLINE: Precision Medicine, Delivery of Health Care, Stakeholder Participation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Personalized prevention is an important component of personalized medicine, tailoring interventions to the biological, behavioral, sociocultural and environmental characteristics of individuals for the prevention of disease onset, progression and recurrence. Despite its potential, personalized preventive interventions (PPI) remain less commonly implemented in clinical practice. This study explored the main barriers to a broader adoption of PPI in European healthcare systems.
Methods
A multi-stakeholder consultation involving citizens/patients, health professionals, researchers, and policymakers was conducted using a sequential mixed-methods approach. In the first phase, semi-structured interviews with key informants representing different stakeholder groups were conducted. The thematic analysis of interview findings, complemented by insights from a review of the literature, informed the development of an online survey implemented in the second phase of the study.
Results
Twenty-six interviews and 270 complete surveys were analyzed. Stakeholders identified barriers across three main domains: (1) healthcare systems, (2) implementation, and (3) awareness, education, and literacy. Key barriers associated with limited PPI adoption included the predominant focus of health strategies on treatment over prevention, unresolved ethical, legal, and social issues (ELSI), limited awareness and knowledge of personalized prevention among both professionals and citizens, and the lack of appropriate cost–benefit evaluation models.
Conclusion
Findings highlight interconnected barriers that may impact a broader PPI adoption across healthcare system, governance, implementation, and awareness-related domains. Continued stakeholder dialogue and engagement, alongside efforts to address awareness and governance-related challenges, may support the broader integration of PPI into European healthcare systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Promotion and NCDs Prevention, National Health of Institute Doctor Ricardo Jorge, Lisbon, Portugal.
- Faculty of Sciences, BioISI-Biosystems and Integrative Sciences Institute, University of Lisbon, Lisbon, Portugal.
- Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
- Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
- Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Zitieren
APA
Costa, A., Cardoso, M. L., Carvalho, A. R., Osti, T., Farina, S., Taha, A., Savoia, C., Russo, L., Maio, A., Scarsi, N., Flodkvist, E., Gyllenberg, A., Boccia, S., & Vicente, A. M. (2026). A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1817705
Vancouver
Costa A, Cardoso ML, Carvalho AR, Osti T, Farina S, Taha A, et al. A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1817705
BibTeX
@article{Costa2026,
author = {Costa, Alexandra and Cardoso, Maria Luís and Carvalho, Adriana Reimão and Osti, Tommaso and Farina, Sara and Taha, Abdelrahman and Savoia, Cosimo and Russo, Luigi and Maio, Alessandra and Scarsi, Nicolò and Flodkvist, Evelina and Gyllenberg, Alexandra and Boccia, Stefania and Vicente, Astrid Moura},
title = {A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1817705}
}
EUVIMED